These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21054394)

  • 1. Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.
    Wei JD; Ho HO; Chen CH; Ke WT; Chen ET; Sheu MT
    J Pharm Pharmacol; 2010 Dec; 62(12):1685-96. PubMed ID: 21054394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.
    Lin YM; Wu JY; Chen YC; Su YD; Ke WT; Ho HO; Sheu MT
    Int J Nanomedicine; 2011; 6():2445-57. PubMed ID: 22072880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
    Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
    Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
    Cho YD; Park YJ
    Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of the drug distribution and mucus diffusion properties of self-microemulsifying drug delivery systems on the oral absorption of fenofibrate.
    Sunazuka Y; Ueda K; Higashi K; Tanaka Y; Moribe K
    Int J Pharm; 2018 Jul; 546(1-2):263-271. PubMed ID: 29763688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems.
    Kim GG; Poudel BK; Marasini N; Lee DW; Hiep TT; Yang KY; Kim JO; Yong CS; Choi HG
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1431-8. PubMed ID: 23046292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate.
    Patel AR; Vavia PR
    AAPS J; 2007 Oct; 9(3):E344-52. PubMed ID: 18170981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.
    Wang Y; Sun J; Zhang T; Liu H; He F; He Z
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.
    O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT
    Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS).
    Lee DW; Marasini N; Poudel BK; Kim JH; Cho HJ; Moon BK; Choi HG; Yong CS; Kim JO
    J Microencapsul; 2014; 31(1):31-40. PubMed ID: 23834315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica.
    Quan G; Wu Q; Zhang X; Zhan Z; Zhou C; Chen B; Zhang Z; Li G; Pan X; Wu C
    Colloids Surf B Biointerfaces; 2016 May; 141():476-482. PubMed ID: 26896653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate.
    Do TT; Van Speybroeck M; Mols R; Annaert P; Martens J; Van Humbeeck J; Vermant J; Augustijns P; Van den Mooter G
    Int J Pharm; 2011 Jul; 414(1-2):118-24. PubMed ID: 21596119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
    Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
    Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Pharmacokinetics Evaluation of Solid Self-Microemulsifying Drug Delivery System (S-SMEDDS) of Osthole.
    Sun C; Gui Y; Hu R; Chen J; Wang B; Guo Y; Lu W; Nie X; Shen Q; Gao S; Fang W
    AAPS PharmSciTech; 2018 Jul; 19(5):2301-2310. PubMed ID: 29845504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of molecular weight of hypromellose on mucin diffusion and oral absorption behavior of fenofibrate nanocrystal.
    Ueda K; Iwai T; Sunazuka Y; Chen Z; Kato N; Higashi K; Moribe K
    Int J Pharm; 2019 Jun; 564():39-47. PubMed ID: 30981872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.